Clinical Trials Browser

Completed × OTHER × Piperacillin, Tazobactam Drug Combination × Clear all

NCT04983901 2026-04-06

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Phase 2 Completed

100 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT03269994 2025-10-21

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Phase 3 Completed

967 enrolled 9 charts

Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

NCT01431326 2023-09-06

PTN_POPS

Completed

3,520 enrolled

CNSClassical hematology

Healthcare-Associated Pneumonia, Pulmonary Arterial Hypertension, Schizophrenia, Treatment-Resistant, Adenoviridae Infections, Anxiety Disorders, Arrhythmias, Cardiac, Autistic Disorder, Bipolar Disorder, Bradycardia, Central Nervous System Infections, Endocarditis, Epilepsy, Headache, Heart Arrest, Heart Failure, Hemophilia A, Herpes Simplex, Hyperaldosteronism, Hypertension, Hypokalemia, Infections, Inflammation, Influenza, Human, Sleep Initiation and Maintenance Disorders, Meningitis, Menorrhagia, Migraine Disorders, Neutropenia, Pain, Pneumonia, Retinitis, Schizophrenia, Seizures, Spasm, Staphylococcal Infections, Urinary Tract Infections, Meningitis, Bacterial, Cytomegalovirus Retinitis, Hemangioma, Capillary, Sepsis, Renal Insufficiency, Chronic, Intraabdominal Infections

NCT03485950 2022-03-15

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Phase 2 Completed

100 enrolled 33 charts

Other Infectious Diseases